Articles Archive - Kongsberg Beam Technology

Interview with CEO Per Håvard Kleven by the Norwegian Cancer Patient Association

Read the interview (only in Norwegian)

Skal hente opptil 20 millioner kroner

Article online

Experienced CEO joins Kongsberg Beam Technology

Kongsberg Hentet inn 13 millioner

Studying medtech with cancer patients at heart

Article online

Semcon responsible for development of revolutionary cancer treatment

Article online

Fikk 22,7 millioner av Forskningsrådet

Skal drepe kreftceller mer effektivt med industriell ammunisjon

Article online

About Kongsberg Beam Technology
Kongsberg Beam Technology strives to become a premier partner for leading companies within the radiation therapy industry. Based on its AI-supported software solution, MaMa-K can substantially enhance the performance and safety of established treatment equipment and dose-planning systems. MaMa-K makes it possible to monitor and predict anatomical and functional changes of a tumour and surrounding tissue, e.g. organs at risk, between treatment sessions. The MaMa-K software will further allow real-time optimisation of delivered radiation. With these unique properties, MaMa-K has the potential to significantly improve treatment outcomes and limit severe short- and long-term side effects.

© 2023 Kongsberg Beam Technology | All rights reserved

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

Archives: Articles

Interview with CEO Per Håvard Kleven by the Norwegian Cancer Patient Association

Skal hente opptil 20 millioner kroner

Skuddpremie på bivirkninger

Experienced CEO joins Kongsberg Beam Technology

Kongsberg Hentet inn 13 millioner

Kreftceller i sikte

Studying medtech with cancer patients at heart

Semcon responsible for development of revolutionary cancer treatment

Fikk 22,7 millioner av Forskningsrådet

Skal drepe kreftceller mer effektivt med industriell ammunisjon

Follow Us

© 2023 Kongsberg Beam Technology | All rights reserved